xlrn stock price
Here are some recent quotes from research analysts about Acceleron Pharma stock: 1  1. Instinet analysts commented, We are initiating coverage of Acceleron (XLRN) with a Buy rating and $58 target price. We recommend owning XLRN shares ahead of what we view as underappreciated 2H17 readouts.
13 brokers have issued 12-month price objectives for Acceleron Pharma's shares. Their forecasts range from $33.00 to $63.00. On average, they expect Acceleron Pharma's stock price to reach $46.91 in the next twelve months.